Five-Year Efficacy and Safety of Ustekinumab Treatment in Crohn’s Disease: The IM-UNITI Trial-Reference-Cited by-同舟云学术

Five-Year Efficacy and Safety of Ustekinumab Treatment in Crohn’s Disease: The IM-UNITI Trial

Published:2021-02 Issue: Volume: Page:
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Sandborn William J.,Rebuck Rory,Wang Yuhua,Zou Bin,Adedokun Omoniyi J.,Gasink Christopher,Sands Bruce E.,Hanauer Stephen B.,Targan Stephan,Ghosh Subrata,de Villiers Willem J.S.,Colombel Jean-Frederic,Feagan Brian G.,Lynch John P.

Funder

Janssen Research and Development LLC

NIDDK

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference15 articles.

1. The natural history of adult Crohn's disease in population-based cohorts;Peyrin-Biroulet;Am J Gastroenterol,2010

2. Crohn's disease;Roda;Nat Rev Dis Primers,2020

3. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial;D'Haens;Lancet,2008

4. Optimizing the use of thiopurines in inflammatory bowel disease;Goel;Ther Adv Chronic Dis,2015

5. Long-term methotrexate for Crohn's disease: safety and efficacy in clinical practice;Domenech;J Clin Gastroenterol,2008

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Recent clinical evidence on nutrition, novel pharmacotherapy, and vaccination in inflammatory bowel diseases;Frontiers in Pharmacology;2024-09-06

3. Combined Advanced Targeted Therapy in Inflammatory Bowel Diseases: An Extensive Update;Inflammatory Bowel Diseases;2024-08-29

4. Small Bowel Cancer in Crohn’s Disease;Cancers;2024-08-21

5. Tuberculosis risk in patients with Crohn’s disease on biologics: a retrospective analysis of the Japanese Medical Claims Database;Intestinal Research;2024-08-19